Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/8491
Title: | Angiogenesis in neurological disorders: A review | Authors: | Acar, Göksemin Tanriöver, G. Demir, R. |
Keywords: | Angiogenesis Anti-angiogenic therapies Neurological disorders Tumor metastasis angiogenesis inhibitor angiotensin II bevacizumab camptothecin cediranib cyclophosphamide erlotinib gefitinib gelatinase A gelatinase B imatinib lomustine nevaxar scatter factor sorafenib thrombospondin 1 unclassified drug vasculotropin vatalanib angiogenesis antiangiogenic activity arteriovenous malformation blood brain barrier brain blood vessel brain disease brain metastasis cancer chemotherapy cancer growth cancer prognosis cell proliferation competitive inhibition down regulation drug efficacy glioblastoma hemangioblastoma hereditary hemorrhagic telengiectasia histopathology human hypertension hypoxemia macrophage maximum tolerated dose meningioma neurologic disease overall survival progression free survival protein expression protein secretion review signal transduction thrombocytopenia tumor cell tumor localization tumor vascularization upregulation vascular tumor Angiogenesis Inhibitors Animals Brain Neoplasms Humans Neovascularization, Pathologic Nervous System Diseases |
Abstract: | Angiogenesis, recruitment of new blood vessels, is an essential component of the metastatic pathway. These vessels provide the principal route by which tumor cells exit the primary tumor site and enter the circulation. For many tumors, the vascular density can provide a prognostic indicator of metastatic potential, with the highly vascular primary tumors having a higher incidence of metastasis than poorly vascular tumors. The discovery and characterization of tumor-derived angiogenesis modulators greatly contributed to our understanding of how tumors regulate angiogenesis. However, although angiogenesis appears to be a rate-limiting event in tumor growth and metastatic dissemination, a direct connection between the induction of angiogenesis and the progression to tumor malignancy is less well understood. In this review, we discuss the observations concerning the modulation of angiogenesis and their implications in various neurological disorders, as well as their potential impact on cancer therapy. © W. S. Maney & Son Ltd 2012. | URI: | https://hdl.handle.net/11499/8491 https://doi.org/10.1179/1743132812Y.0000000068 |
ISSN: | 0161-6412 |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Show full item record
CORE Recommender
SCOPUSTM
Citations
3
checked on Nov 16, 2024
WEB OF SCIENCETM
Citations
3
checked on Nov 21, 2024
Page view(s)
34
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.